A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements

A synthetic stimulant never before studied in humans, 1,3‐dimethylbutylamine (DMBA), was suspected of being present in dietary supplements. DMBA is an analogue of the pharmaceutical stimulant, 1,3‐dimethylamylamine (DMAA), which was recently banned by the US Food and Drug Administration. We obtained...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug testing and analysis 2015-01, Vol.7 (1), p.83-87
Hauptverfasser: Cohen, Pieter A., Travis, John C., Venhuis, Bastiaan J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 87
container_issue 1
container_start_page 83
container_title Drug testing and analysis
container_volume 7
creator Cohen, Pieter A.
Travis, John C.
Venhuis, Bastiaan J.
description A synthetic stimulant never before studied in humans, 1,3‐dimethylbutylamine (DMBA), was suspected of being present in dietary supplements. DMBA is an analogue of the pharmaceutical stimulant, 1,3‐dimethylamylamine (DMAA), which was recently banned by the US Food and Drug Administration. We obtained all dietary supplements sold by US distributors that listed an ingredient on the label, such as AMP Citrate, that might be a marketing name for DMBA. Supplements were analyzed for the presence and quantity of DMBA. Fourteen supplements met our inclusion criteria and were analyzed by two separate laboratories using ultra high performance liquid chromatography (UHPLC) ‐ mass spectrometry and a reference standard. The identity of DMBA was confirmed in 12 supplements in the range of 13 to 120 mg DMBA per serving. Following recommendations on the supplement label for maximum daily intake, customers would consume from 26 to 320 mg of DMBA per day. Supplements containing DMBA were marketed to improve athletic performance, increase weight loss and enhance brain function. DMBA has never before been detected in supplements. The stimulant has never been studied in humans; its efficacy and safety are entirely unknown. Regulatory agencies should act expeditiously to warn consumers and remove DMBA from all dietary supplements. Copyright © 2014 John Wiley & Sons, Ltd. A new stimulant, 1,3‐Dimethylbutylamine (DMBA), is detected and quantified in multiple dietary supplements. DMBA was detected in 12 supplements in the range of 13 to 120 mg DMBA per serving.
doi_str_mv 10.1002/dta.1735
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1652404958</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3568254971</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4575-4f721513c659b46a5314cc6d34c2934ddbc0165420f99ee6a1d696e8c583924c3</originalsourceid><addsrcrecordid>eNp1kV1rFDEUhoNYbLsK_gIJeFNhp-Y7m8u1q2uhVcSKlyGbnGFTZ2bXScY6_npTdt2C0KucwHMezsuL0EtKzikh7G3I7pxqLp-gE2oEq7Si9OlhJvwYnaZ0S4gSjMtn6JhJZrgk5gT9meM0dnkNOXqccmyHxnUZd_ALepwhZQg4dng9tK5LU0ynvAqxhbwem9WQx8a1sQN8trh-N38zxTHhGKDLsY67vaLLcdsADhGy60echm35toVJz9FR7ZoEL_bvBH378P7m4mN19Xl5eTG_qryQWlai1oxKyr2SZiWUk5wK71XgwpcQIoSVJ1RJwUhtDIByNCijYObljBsmPJ-gs513229-DiWSbWPy0JSgsBmSLctMEGEKP0Gv_0NvN0PflesKJbSRZCbNg9D3m5R6qO22j21JZymx933Y0oe976Ogr_bCYdVCOID_CihAtQPuYgPjoyK7uJnvhXs-lmp-H3jX_7BKcy3t909Lu-SLxbXWX-0X_hf556H6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1647950859</pqid></control><display><type>article</type><title>A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Cohen, Pieter A. ; Travis, John C. ; Venhuis, Bastiaan J.</creator><creatorcontrib>Cohen, Pieter A. ; Travis, John C. ; Venhuis, Bastiaan J.</creatorcontrib><description>A synthetic stimulant never before studied in humans, 1,3‐dimethylbutylamine (DMBA), was suspected of being present in dietary supplements. DMBA is an analogue of the pharmaceutical stimulant, 1,3‐dimethylamylamine (DMAA), which was recently banned by the US Food and Drug Administration. We obtained all dietary supplements sold by US distributors that listed an ingredient on the label, such as AMP Citrate, that might be a marketing name for DMBA. Supplements were analyzed for the presence and quantity of DMBA. Fourteen supplements met our inclusion criteria and were analyzed by two separate laboratories using ultra high performance liquid chromatography (UHPLC) ‐ mass spectrometry and a reference standard. The identity of DMBA was confirmed in 12 supplements in the range of 13 to 120 mg DMBA per serving. Following recommendations on the supplement label for maximum daily intake, customers would consume from 26 to 320 mg of DMBA per day. Supplements containing DMBA were marketed to improve athletic performance, increase weight loss and enhance brain function. DMBA has never before been detected in supplements. The stimulant has never been studied in humans; its efficacy and safety are entirely unknown. Regulatory agencies should act expeditiously to warn consumers and remove DMBA from all dietary supplements. Copyright © 2014 John Wiley &amp; Sons, Ltd. A new stimulant, 1,3‐Dimethylbutylamine (DMBA), is detected and quantified in multiple dietary supplements. DMBA was detected in 12 supplements in the range of 13 to 120 mg DMBA per serving.</description><identifier>ISSN: 1942-7603</identifier><identifier>EISSN: 1942-7611</identifier><identifier>DOI: 10.1002/dta.1735</identifier><identifier>PMID: 25293509</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>adulteration ; Amines - analysis ; dietary supplements ; Dietary Supplements - analysis ; Drug Contamination ; Humans ; stimulants ; Tandem Mass Spectrometry</subject><ispartof>Drug testing and analysis, 2015-01, Vol.7 (1), p.83-87</ispartof><rights>Copyright © 2014 John Wiley &amp; Sons, Ltd.</rights><rights>Copyright © 2015 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4575-4f721513c659b46a5314cc6d34c2934ddbc0165420f99ee6a1d696e8c583924c3</citedby><cites>FETCH-LOGICAL-c4575-4f721513c659b46a5314cc6d34c2934ddbc0165420f99ee6a1d696e8c583924c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fdta.1735$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fdta.1735$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25293509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cohen, Pieter A.</creatorcontrib><creatorcontrib>Travis, John C.</creatorcontrib><creatorcontrib>Venhuis, Bastiaan J.</creatorcontrib><title>A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements</title><title>Drug testing and analysis</title><addtitle>Drug Test. Analysis</addtitle><description>A synthetic stimulant never before studied in humans, 1,3‐dimethylbutylamine (DMBA), was suspected of being present in dietary supplements. DMBA is an analogue of the pharmaceutical stimulant, 1,3‐dimethylamylamine (DMAA), which was recently banned by the US Food and Drug Administration. We obtained all dietary supplements sold by US distributors that listed an ingredient on the label, such as AMP Citrate, that might be a marketing name for DMBA. Supplements were analyzed for the presence and quantity of DMBA. Fourteen supplements met our inclusion criteria and were analyzed by two separate laboratories using ultra high performance liquid chromatography (UHPLC) ‐ mass spectrometry and a reference standard. The identity of DMBA was confirmed in 12 supplements in the range of 13 to 120 mg DMBA per serving. Following recommendations on the supplement label for maximum daily intake, customers would consume from 26 to 320 mg of DMBA per day. Supplements containing DMBA were marketed to improve athletic performance, increase weight loss and enhance brain function. DMBA has never before been detected in supplements. The stimulant has never been studied in humans; its efficacy and safety are entirely unknown. Regulatory agencies should act expeditiously to warn consumers and remove DMBA from all dietary supplements. Copyright © 2014 John Wiley &amp; Sons, Ltd. A new stimulant, 1,3‐Dimethylbutylamine (DMBA), is detected and quantified in multiple dietary supplements. DMBA was detected in 12 supplements in the range of 13 to 120 mg DMBA per serving.</description><subject>adulteration</subject><subject>Amines - analysis</subject><subject>dietary supplements</subject><subject>Dietary Supplements - analysis</subject><subject>Drug Contamination</subject><subject>Humans</subject><subject>stimulants</subject><subject>Tandem Mass Spectrometry</subject><issn>1942-7603</issn><issn>1942-7611</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kV1rFDEUhoNYbLsK_gIJeFNhp-Y7m8u1q2uhVcSKlyGbnGFTZ2bXScY6_npTdt2C0KucwHMezsuL0EtKzikh7G3I7pxqLp-gE2oEq7Si9OlhJvwYnaZ0S4gSjMtn6JhJZrgk5gT9meM0dnkNOXqccmyHxnUZd_ALepwhZQg4dng9tK5LU0ynvAqxhbwem9WQx8a1sQN8trh-N38zxTHhGKDLsY67vaLLcdsADhGy60echm35toVJz9FR7ZoEL_bvBH378P7m4mN19Xl5eTG_qryQWlai1oxKyr2SZiWUk5wK71XgwpcQIoSVJ1RJwUhtDIByNCijYObljBsmPJ-gs513229-DiWSbWPy0JSgsBmSLctMEGEKP0Gv_0NvN0PflesKJbSRZCbNg9D3m5R6qO22j21JZymx933Y0oe976Ogr_bCYdVCOID_CihAtQPuYgPjoyK7uJnvhXs-lmp-H3jX_7BKcy3t909Lu-SLxbXWX-0X_hf556H6</recordid><startdate>201501</startdate><enddate>201501</enddate><creator>Cohen, Pieter A.</creator><creator>Travis, John C.</creator><creator>Venhuis, Bastiaan J.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201501</creationdate><title>A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements</title><author>Cohen, Pieter A. ; Travis, John C. ; Venhuis, Bastiaan J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4575-4f721513c659b46a5314cc6d34c2934ddbc0165420f99ee6a1d696e8c583924c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>adulteration</topic><topic>Amines - analysis</topic><topic>dietary supplements</topic><topic>Dietary Supplements - analysis</topic><topic>Drug Contamination</topic><topic>Humans</topic><topic>stimulants</topic><topic>Tandem Mass Spectrometry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cohen, Pieter A.</creatorcontrib><creatorcontrib>Travis, John C.</creatorcontrib><creatorcontrib>Venhuis, Bastiaan J.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Drug testing and analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cohen, Pieter A.</au><au>Travis, John C.</au><au>Venhuis, Bastiaan J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements</atitle><jtitle>Drug testing and analysis</jtitle><addtitle>Drug Test. Analysis</addtitle><date>2015-01</date><risdate>2015</risdate><volume>7</volume><issue>1</issue><spage>83</spage><epage>87</epage><pages>83-87</pages><issn>1942-7603</issn><eissn>1942-7611</eissn><abstract>A synthetic stimulant never before studied in humans, 1,3‐dimethylbutylamine (DMBA), was suspected of being present in dietary supplements. DMBA is an analogue of the pharmaceutical stimulant, 1,3‐dimethylamylamine (DMAA), which was recently banned by the US Food and Drug Administration. We obtained all dietary supplements sold by US distributors that listed an ingredient on the label, such as AMP Citrate, that might be a marketing name for DMBA. Supplements were analyzed for the presence and quantity of DMBA. Fourteen supplements met our inclusion criteria and were analyzed by two separate laboratories using ultra high performance liquid chromatography (UHPLC) ‐ mass spectrometry and a reference standard. The identity of DMBA was confirmed in 12 supplements in the range of 13 to 120 mg DMBA per serving. Following recommendations on the supplement label for maximum daily intake, customers would consume from 26 to 320 mg of DMBA per day. Supplements containing DMBA were marketed to improve athletic performance, increase weight loss and enhance brain function. DMBA has never before been detected in supplements. The stimulant has never been studied in humans; its efficacy and safety are entirely unknown. Regulatory agencies should act expeditiously to warn consumers and remove DMBA from all dietary supplements. Copyright © 2014 John Wiley &amp; Sons, Ltd. A new stimulant, 1,3‐Dimethylbutylamine (DMBA), is detected and quantified in multiple dietary supplements. DMBA was detected in 12 supplements in the range of 13 to 120 mg DMBA per serving.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>25293509</pmid><doi>10.1002/dta.1735</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1942-7603
ispartof Drug testing and analysis, 2015-01, Vol.7 (1), p.83-87
issn 1942-7603
1942-7611
language eng
recordid cdi_proquest_miscellaneous_1652404958
source MEDLINE; Wiley Online Library All Journals
subjects adulteration
Amines - analysis
dietary supplements
Dietary Supplements - analysis
Drug Contamination
Humans
stimulants
Tandem Mass Spectrometry
title A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A05%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20synthetic%20stimulant%20never%20tested%20in%20humans,%201,3-dimethylbutylamine%20(DMBA),%20is%20identified%20in%20multiple%20dietary%20supplements&rft.jtitle=Drug%20testing%20and%20analysis&rft.au=Cohen,%20Pieter%20A.&rft.date=2015-01&rft.volume=7&rft.issue=1&rft.spage=83&rft.epage=87&rft.pages=83-87&rft.issn=1942-7603&rft.eissn=1942-7611&rft_id=info:doi/10.1002/dta.1735&rft_dat=%3Cproquest_cross%3E3568254971%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1647950859&rft_id=info:pmid/25293509&rfr_iscdi=true